Cena / účetní hodnota společnosti Medicrea International SA
Jaká je hodnota metriky Cena / účetní hodnota společnosti Medicrea International SA?
Hodnota metriky Cena / účetní hodnota společnosti Medicrea International SA je -24,555.82
Jaká je definice metriky Cena / účetní hodnota?
Cena / učetní hodnota (Price to book ratio) je ukazatel, který vyjadřuje poměr mezi hodnotou společnosti a book value společnosti, což je hodnota čistých aktiv.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena / účetní hodnota společností v sektoru Health Care sektor na LSE ve srovnání se společností Medicrea International SA
Čemu se věnuje společnost Medicrea International SA?
Medicrea International SA designs, manufactures, and distributes spinal implants in France and internationally. It offers PASS range, a polyaxial spine system; PASS LP, a thoraco-lumbar fixation system; LigaPASS, a band connector for posterior thoracolumbar fixation; PASS TULIP, a top loading posterior fixation system; PASS DEGEN for thoracic and lumbar degenerative indications; PASS OCT, an occipito-cervico-thoracic fixation system; PASS MIS, a posterior anchoring system; PASS Antérieur that offers a range of specific implants enabling surgery using an anterior approach; IMPIX C, a sterile PEEK Optima cervical interbody device; IMPIX-C+, a sterile PEEK Optima cervical interbody device that is prefilled with bone substitute; and IMPIX-MANTA, a sterile PEEK Optima cervical interbody device that is preassembled on holder/ impactor and delivers with a disposable instrumentation kit. Its implants for cervical spine also include IMPIX-MANTA +, a sterile PEEK Optima cervical interbody device, which is prefilled with synthetic bone substitutes; and GRANVIA-C, a MRI compatible ceramic cervical disc. In addition, it provides implants for the thoracic and lumbar spine, such as IMPIX-L, a sterile PEEK Optima lumbar interbody device for posterior approach; IMPIX-TLIF, a sterile PEEK Optima lumbar interbody device for transforaminal approach with a pre-assembled PEEK control lead; IMPIX-ALIF, a sterile PEEK Optima lumbar interbody device for anterior approach; STABOLT, an anatomically-shaped anterior plate; OSMOSYS, a macroporous bone substitute; IMPIX-DLIF and IMPIX-DLIF SLIM sterile PEEK Optima lumbar interbody devices for direct or oblique lateral approach; and X-JAWS, a titanium lumbar staple to secure a lateral or an anterior cage. Its implants are designed to treat scoliosis, degenerative diseases, malformations, trauma, and tumors; and used in various traditional and surgical procedures. The company was founded in 1990 and is headquartered in Rillieux-la-Pape, France.
Firmy s metrikou cena / účetní hodnota podobnou společnosti Medicrea International SA
- Hodnota metriky Cena / účetní hodnota společnosti B. Riley Principal Merger II je -879,857.40
- Hodnota metriky Cena / účetní hodnota společnosti Nexway AG je -379,988.75
- Hodnota metriky Cena / účetní hodnota společnosti Gores IV je -261,955.11
- Hodnota metriky Cena / účetní hodnota společnosti PyroGenesis Canada je -72,455.37
- Hodnota metriky Cena / účetní hodnota společnosti Bangfu Technology Co je -70,671.11
- Hodnota metriky Cena / účetní hodnota společnosti Social Capital Hedosophia Holdi je -70,527.95
- Hodnota metriky Cena / účetní hodnota společnosti Medicrea International SA je -24,555.82
- Hodnota metriky Cena / účetní hodnota společnosti Impelus je -23,000.00
- Hodnota metriky Cena / účetní hodnota společnosti Bowen Fintech PLC je -22,500.00
- Hodnota metriky Cena / účetní hodnota společnosti Clancy je -16,739.07
- Hodnota metriky Cena / účetní hodnota společnosti Crucial Innovations je -8,458.45
- Hodnota metriky Cena / účetní hodnota společnosti Sands China je -6,711.72
- Hodnota metriky Cena / účetní hodnota společnosti Sands China je -6,662.79